Literature DB >> 33926816

Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.

Loreta A Kondili1, Alessio Aghemo2, Massimo Andreoni3, Massimo Galli4, Alessandro Rossi5, Sergio Babudieri6, Felice Nava7, Claudio Leonardi8, Francesco Saverio Mennini9, Ivan Gardini10, Francesco Paolo Russo11.   

Abstract

Although Italy has been on track for Hepatitis C Virus (HCV) elimination since 2019, it fell off track due to the decrease in the number of treated patients. HCV elimination in Italy will be possible if immediate action is taken. A health policy was implemented beginning in 2021, consisting of screening among key populations and birth cohorts (1969-1989), estimated to have a high prevalence of undiagnosed individuals. The active screening requires regional governance that manages the processes' complexity integrating a well-organized network between territory assistance and hospital to achieve an effective HCV care cascade. This document aims to support the regional decision-making process by defining paths for screening and linkage-to-care. Implementing active screening strategies beyond a risk-based approach is required as a General Practitioners' task. Simplified paths must be drawn for the key populations screening. The infrastructure built for COVID-19 vaccination could be used also for HCV screening. According to a multidisciplinary care delivery, screening should be supplemented with rapid linkage-to-care and treatment of newly diagnosed patients. The realization of the proactive screening during the first two years is vital because it will define the tracks for the whole HCV cost-effective screening of 1948-1988 birth cohorts in Italy.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Birth cohort screening; HCV chronic infection; Key population; WHO elimination targets

Mesh:

Substances:

Year:  2021        PMID: 33926816     DOI: 10.1016/j.dld.2021.03.026

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  5 in total

1.  Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.

Authors:  Valerio Rosato; Loreta A Kondili; Riccardo Nevola; Pasquale Perillo; Davide Mastrocinque; Alessio Aghemo; Ernesto Claar
Journal:  Viruses       Date:  2022-05-19       Impact factor: 5.818

2.  Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation.

Authors:  Andrea Marcellusi; Francesco Saverio Mennini; Murad Ruf; Claudio Galli; Alessio Aghemo; Maurizia R Brunetto; Sergio Babudieri; Antonio Craxi; Massimo Andreoni; Loreta A Kondili
Journal:  Liver Int       Date:  2021-10-08       Impact factor: 8.754

3.  Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection.

Authors:  Loreta A Kondili; Lucia Craxì; Massimo Andreoni; Francesco S Mennini; Homie Razavi
Journal:  Liver Int       Date:  2022-05       Impact factor: 8.754

4.  Hepatitis C virus burden: Treating and educating people without prejudice.

Authors:  Elettra Merola; Elisa Menotti; Giovanna Branz; Andrea Michielan; Sonia Seligmann; Annora Ratti; Flora Agugiaro; Luisa Moser; Giovanni Vettori; Anna Franceschini; William Mantovani; Riccardo Pertile; Giovanni de Pretis; Cecilia Pravadelli
Journal:  World J Hepatol       Date:  2022-07-27

5.  HCV point of care screening in people tested for SARS-CoV-2 in a social-housing neighbourhood of Milan, Italy.

Authors:  Martina Beltrami; Gabriele Pagani; Federico Conti; Laura Pezzati; Giacomo Casalini; Rossana Rondanin; Andrea Prina; Antonino Zagari; Massimo Galli; Andrea Giacomelli
Journal:  Liver Int       Date:  2022-07-22       Impact factor: 8.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.